Pixium Vision
Develops retinal implant systems for patients who have lost their eyesight.
Market cap
$1.7m
Enterprise value
$22m
Share price
€0.38 PIX.PA
Company register number
538797655
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | €1.8m | Post IPO Debt | |
| Total Funding | 000k | ||
Bpifrance(exited)
Omnes Capital(exited)
Sofinnova Partners(exited)
InnoBio(exited)
Abingworth(exited)
Kreos Capital(exited)
Kepler Cheuvreux(exited)
Agoranov(exited)
Seventure Partners(exited)
IBionext(exited)
SATT LUTECH(exited)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 50 % | (33 %) | - | (50 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (300 %) | (400 %) | (350 %) | (333 %) | (550 %) | (530 %) | 550 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (700 %) | (500 %) | (450 %) | (367 %) | (500 %) | (620 %) | 340 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 100 % | - | - | - | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.